Subscribe
Share
Share
Embed
Montreal-based Repare Therapeutics has entered a deal (potentially worth US$1.2 billion) with pharma giant F Hoffman La Roche to create a new drug to treat cancerous tumours.
Almost half of Canada’s asset managers, researchers and lenders are “not very satisfied” or “totally dissatisfied” with available company data for so-called “green” investments,
One estimate suggests that inflation has offset two-thirds of the buying power of Canadians after the pandemic
The Peak Daily is produced by 306 Media Productions. Hosted by Brett Chang and Jay Rosenthal.
Montreal-based Repare Therapeutics has entered a deal (potentially worth US$1.2 billion) with pharma giant F Hoffman La Roche to create a new drug to treat cancerous tumours.
Almost half of Canada’s asset managers, researchers and lenders are “not very satisfied” or “totally dissatisfied” with available company data for so-called “green” investments,
One estimate suggests that inflation has offset two-thirds of the buying power of Canadians after the pandemic
The Peak Daily is produced by 306 Media Productions. Hosted by Brett Chang and Jay Rosenthal.
Fast Canadian business news. Get up-to-speed quick with a fun and smart breakdown of the three biggest Canadian and global business stories in less than 10 minutes.